MM

Marissa Moore

Principal and Vertical Software Lead at OMERS Ventures

San Francisco Bay Area

Overview

Work Experience

  • Principal | Vertical Software Lead

    2022 - Current

    I'm primarily spending time on vertical software/AI defining resilience in public health and safety (e.g., healthcare, life sciences, law enforcement/public safety, national security, etc.), industrial & supply chain (e.g., manufacturing, freight & logistics, etc.), and critical resources & infrastructure (e.g., oil & gas, alt energy, power, utilities, telecom, etc.). OMERS Ventures is the direct, early-stage venture arm of the $127B NAV Canadian pension plan Ontario Municipal Employee Retirement System (OMERS). OMERS manages the pension benefits for 600k municipal workers (e.g., nurses, firefighters, police officers, etc.) in the province of Ontario. We’re currently investing out of our 4th fund, focusing on horizontal B2B software/AI, vertical B2B software/AI, fintech/insurtech, and infrastructure software. We invest in Series A-C rounds with checks ranging in size from $5-25M. Example investments include Shopify, Hopper, Hootsuite, DuckDuckGo, Deliverect, Jobber, Altana, and Mosaic.tech. Under the OMERS umbrella, we also have Growth Equity, Private Equity Buyouts, Infrastructure, Real Estate (Oxford Properties), and Capital Markets strategies.

  • Managing Analyst - Healthcare

    2019 - 2021

    Primary focus areas: MedTech & Telehealth

  • Graduate Teaching Assistant - Biopharmaceutical Strategy

    2019 - 2019

  • AVP, Equity Research

    2017 - 2019

    Coverage Areas: Industrial Machinery, Cannabis

  • Director of Business Development

    2017 - 2017

  • AVP, Institutional Equity Sales

    2013 - 2017

    Passed levels I, II, and III of the Chartered Financial Analyst Program

  • Molecular Biology Undergraduate Thesis Researcher, Gavis Lab

    2011 - 2013

    Focus areas: NEUROSCIENCE, GENETICS, CELLULAR DEVELOPMENT ◻ Independently researched & developed methods for screening mRNA asymmetrically localized in D. melanogaster neuromuscular junctions. ◻ Utilized the EP-MS2 method (combining EP transposon insertion with MS2/MCP in vivo fluorescent labeling) to screen for novel localized mRNA transcripts. The goal was to identify which transcripts were asymmetrically localized and then to determine their possible roles in cellular development. ◻ Research was presented as a senior thesis in May of 2013 and was partially included in a scientific publication in G3 Journal in August of 2016 (see publications below).

  • Global Markets Summer Analyst

    2012 - 2012

Relevant Websites